Documentation

Docs, README files, API references, tutorials, specs, and changelogs

skills in category: 16,081
pages available: 671

Security grades appear on each card once the skill has been scanned. Newly imported skills may briefly show without a grade until the backfill job runs.

Open in full browser

Browse documentation skills

Showing 8,089–8,112 of 16,081 skills

Endo Hirsutism No Preference Antiandrogen Avoid FlutamideAFor women with patient-important hirsutism despite cosmetic measures who have suboptimal response after ≥6 months of oral contraceptive monotherapy, consider adding an antiandrogen; no preference among antiandrogens but avoid flutamide due to its hepatotoxicity risk.documentationrailsVotes: 0GitHub stars: 12
Endo Hirsutism Either Approach Mild No EndocrineAFor a premenopausal woman presenting with mild hirsutism (Ferriman–Gallwey score 8–15) and no clinical evidence of an endocrine disorder (eumenorrheic menses, absence of hyperandrogenic signs), the clinician should consider either pharmacologic therapy or direct hair removal as initial management options. Choose pharmacologic therapy (e.g., combined oral contraceptive) or direct hair removal (laser/photoepilation or electrolysis) based on patient preference, contraceptive needs, and hair char...documentationgorailsVotes: 0GitHub stars: 12
Endo Hirsutism Avoid Topical AntiandrogenAThe skill advises clinicians to avoid prescribing topical antiandrogen agents (e.g., spironolactone or finasteride cream) for hirsutism in premenopausal women. Trigger phrases include “patient wants a topical cream for facial hair,” “considering eflornithine for hirsutism,” or “requests antiandrogen topical therapy.”documentationrailsVotes: 0GitHub stars: 12
Endo Hirsutism Avoid Antiandrogen Monotherapy Unless ContraceptionAGuidance to avoid antiandrogen monotherapy unless adequate contraception is in place. Trigger phrases include patient-important hirsutism despite cosmetic measures, sexually active status, inadequate contraception, desire for pregnancy, permanent sterilization, or long-acting reversible contraception.documentationrailsVotes: 0GitHub stars: 12
Endo Fha Physical Exam Organic ExclusionAThis skill directs clinicians to conduct a thorough physical exam, including external and selected bimanual gynecologic exam, to identify signs of anatomic or organic causes of amenorrhea. Use when clinicians state, 'Let’s check for thyroid enlargement, galactorrhea, or pelvic masses,' or 'Perform bimanual to rule out outflow tract anomalies' or 'Look for hirsutism, acne, or signs of androgen excess'.documentationrailsVotes: 0GitHub stars: 12
Ata Male Hypogonadism LabsAThis skill guides ordering initial labs (serum testosterone, FSH, and LH) to evaluate suspected central hypogonadism in adult males. Use when a male presents with low libido, fatigue, decreased energy, or other signs suggestive of gonadal deficiency.documentationgorailsVotes: 0GitHub stars: 12
Skills DirectorySkills Directory Look up any of 103,619 scanned skills — grade, score, and every finding. Free.Check a skill
Wegovy Prescribing GuideABedside prescribing reference for Wegovy (semaglutide 2.4 mg) — adult and pediatric indications, 16-week dose-escalation schedule, missed-dose rule, 12-week continuation rule, contraindications, warnings, and monitoring. Use when a clinician asks how to start Wegovy, how to titrate semaglutide 2.4 mg, Wegovy pediatric indication, missed Wegovy dose, Wegovy contraindications, or when a patient on Wegovy needs a monograph-level clinical decision. Grounded in the Canadian Product Monograph (Novo...documentationgoreactVotes: 0GitHub stars: 12
Glp1 Obesity Agent Nv ProfileALook up drug-specific nausea and vomiting rates across the full generation of GLP-1-based obesity agents — semaglutide 2.4 mg, semaglutide 7.2 mg, CagriSema, tirzepatide, retatrutide, survodutide, oral semaglutide 25/50 mg, and orforglipron — to counsel patients before initiation or to decide which agent to switch to when tolerability is the deciding factor. Use when a clinician asks "how much nausea should I expect on Wegovy vs Zepbound", "retatrutide vs semaglutide tolerability", "CagriSema...documentationgoapiVotes: 0GitHub stars: 12
Glp1 Gi Ae Symptom AdvisorAProvide symptom-specific dietary and lifestyle advice for a patient on a GLP-1 receptor agonist who has developed nausea, vomiting, diarrhoea, or constipation. Use when a clinician asks "what to advise for nausea/vomiting/diarrhoea/constipation on semaglutide/liraglutide/tirzepatide", or any GLP-1 patient with a specific GI symptom needs targeted non-pharmacological advice. Outputs a focused do/avoid list per symptom, grounded in the Gorgojo-Martínez 2023 consensus (Figure 2).documentationgoVotes: 0GitHub stars: 12
Glp1 Gi Ae Pharmacological RescueASelect the right rescue medication for GI adverse events caused by a GLP-1 receptor agonist — antiemetics for nausea/vomiting, antidiarrhoeals for diarrhoea, stool softeners for constipation, plus drug-interaction adjustments. Use when a clinician asks "which antiemetic on semaglutide", "domperidone vs metoclopramide for GLP-1 nausea", "loperamide for liraglutide diarrhoea", or asks for pharmacological rescue when diet/lifestyle alone has failed. Grounded in Gorgojo-Martínez 2023 §4.3 and Fig...documentationgoVotes: 0GitHub stars: 12
Es Determine Hysterectomy Oophorectomy NecessityAAssesses whether hysterectomy and oophorectomy are medically necessary as part of gender-affirming surgery for transgender patients. Triggered when a patient is planning gender-affirming surgery and clinicians need to determine if total hysterectomy and oophorectomy should be included.documentationgorailsVotes: 0GitHub stars: 12
Es Check One Year Hormone Therapy SurgeryADetermines if a patient has completed ≥1 year of consistent and compliant hormone therapy for genital surgery approval. Triggers include patient requesting genital surgery and being on hormone therapy.documentationgorailsVotes: 0GitHub stars: 12
Es Check Adult Hormone Therapy EligibilityADetermines whether an adult patient meets eligibility criteria for initiating gender-affirming hormone therapy. Triggered when an adult patient requests gender-affirming hormones or presents for evaluation of hormone therapy eligibility.documentationrailsdocumentationVotes: 0GitHub stars: 12
Es Check Adolescent Sex Hormone EligibilityADetermines if an adolescent meets criteria for initiating sex hormone treatment for gender dysphoria/gender incongruence. Triggered when an adolescent requests sex hormones or presents for gender-affirming hormone therapy evaluation.documentationrailsdocumentationVotes: 0GitHub stars: 12
Es Calculate Pubertal Induction DoseACalculates initial and escalating dose for pubertal induction hormone therapy based on patient weight or body surface area. Triggers include patient eligible for sex hormone treatment, ready to start hormones.documentationrailsdocumentationVotes: 0GitHub stars: 12
Es Pump Hybrid ContinuationAThis skill determines whether a patient using a hybrid closed-loop insulin pump can continue this therapy upon hospital admission. It is triggered by questions such as "Can hybrid closed-loop pump be continued given hospital constraints?"documentationrailsVotes: 0GitHub stars: 12
Es Pump Hospital PoliciesAThis skill confirms whether a hospital has the necessary policies and expertise to support inpatient insulin pump therapy, including informed consent, standardized order sets, and device management guidance for imaging and surgical procedures. Triggered by questions such as "Are hospital policies and expertise in place for insulin pump use?" to ensure safe continuation of pump therapy in noncritical illness.documentationrailsVotes: 0GitHub stars: 12
Endo Csii Over Mdi T1dm Not At A1c GoalARecommends CSII over analog-based basal-bolus MDI for adults with T1DM who have not achieved their A1C goal, provided patient and caregivers are willing and able to use the device. Trigger phrases include 'Patient’s A1C is above target despite MDI' and 'Consider pump for uncontrolled T1DM'.documentationgorailsVotes: 0GitHub stars: 12
Pdm Contraception UseARecommends contraception when pregnancy is not desired for individuals with diabetes who could become pregnant. Triggered by discussions about pregnancy planning, contraception needs, or when pregnancy is not desired.documentationgorailsVotes: 0GitHub stars: 12
Es Cushing Shared Decision Making Second Line TherapiesAThis skill provides a shared decision-making framework for selecting second-line therapies in patients with ACTH-dependent Cushing's syndrome who have persistent hypercortisolism after transsphenoidal surgery or for whom surgery is not feasible. Clinical triggers include "failed TSS", "non-curative pituitary surgery", "persistent UFC elevation post-op", and "surgery contraindicated".documentationgorailsVotes: 0GitHub stars: 12
Es Cushing Glucocorticoid Antagonist Diabetes Glucose IntoleranceAThis skill suggests administering a glucocorticoid antagonist (e.g., mifepristone) in patients with Cushing's disease who have diabetes or glucose intolerance and are not surgical candidates or have persistent disease after transsphenoidal surgery. Consider when encountering persistent hypercortisolism after TSS, contraindications to surgery, or comorbid diabetes/glucose intolerance requiring medical control.documentationgorailsVotes: 0GitHub stars: 12
Jes Pa Treatment SelectionADetermines whether to recommend adrenalectomy or mineralocorticoid receptor antagonists for primary aldosteronism based on PA subtype and patient/surgical factors. Triggered after subtype confirmation when clinicians ask “Should this patient have surgery or medical treatment?” or discuss treatment options with the patient.documentationgorailsVotes: 0GitHub stars: 12
Jes Pa Screening SamplingAProvides guidance on acceptable blood sampling conditions for primary aldosteronism screening when ideal early‑morning supine fasting conditions cannot be met. Triggers include when a clinician says “The patient wasn’t fasting/supine” or questions whether non‑ideal sampling affects screening validity.documentationgorailsVotes: 0GitHub stars: 12
Esa Pa Treatment UnilateralADetermines whether to recommend unilateral laparoscopic adrenalectomy or medical therapy with a mineralocorticoid receptor antagonist for patients with confirmed unilateral PA (aldosterone-producing adenoma or unilateral adrenal hyperplasia). Triggered when discussing treatment options after confirming unilateral PA in a hypertensive patient with hypokalemia or resistant hypertension.documentationgorailsVotes: 0GitHub stars: 12